Buying interest flowed into domestic pharmaceutical and diagnostics stocks amid concerns about the spread of an infectious disease following the death of an employee at a Russian research institute. The related stocks rose even as the broader market weakened. However, local health authorities said the disease had not been confirmed, and an international health organization assessed the public health risk as limited. Investors should evaluate whether to invest by examining the treatments and diagnostic products companies actually have, and how closely their businesses are connected to the situation, rather than focusing solely on rumors of an outbreak.


Those considering additional purchases in the pharmaceutical and diagnostics sectors can review the amount of investment capital they need alongside the business outlook. Depending on the terms of use, stock loan services that allow investors to deploy up to four times their available funds, including their own capital, are an option for buying more of stocks they are interested in and broadening their investment choices. Investors already using securities credit or margin trading can also consider refinancing. Comparing interest rates, additional fees, and collateral maintenance requirements can help investors identify terms suited to their accounts and develop a concrete funding plan, from securing additional investment capital to managing the costs of existing transactions.


Among these services, All New Stock Loan is drawing attention for offering a range of products with different terms, including products with annual interest rates in the 5% range. It is being viewed as an option for investors seeking to broaden their investment opportunities while also taking costs into account.

Pharma and Diagnostics Stocks Rise on Infectious Disease Concerns... Investors Should Secure Capital Based on Business Outlook View original image

* All New Stock Loan launches a product with an industry-low annual interest rate in the 5% range!

All New Stock Loan has launched a securities-linked credit product available at an industry-low annual interest rate in the 5% range, allowing investors to use a stock loan service without undue financial burden. The service can be used both to purchase stocks and to refinance securities margin or credit transactions, and investors can use up to four times their own capital, with no differences based on credit rating. Investors using the alternative trading system (NXT) can also use the service.


Investors who would like to learn more about All New Stock Loan can contact its customer service center at 1599-8666 to speak with a professional counselor at any time, regardless of whether they qualify for a loan.


- Industry-low annual interest rate in the 5% range!

- ETF trading available

- Use up to four times your own capital for stock investments!

- Same-day refinancing of securities credit or margin transactions available!

- Trading on the alternative trading system (NXT) available

- OK to buy stocks that were difficult to purchase using existing securities credit or stock loans!

* All New Stock Loan Customer Service Center: 1599-8666

Link: https://allnewstockloan.co.kr


SK hynix, Doosan Enerbility, Hyundai Motor, Kukje Pharma, Leeno Industrial



※ This content is unrelated to The Asia Business Daily's editorial direction, and the information provider bears all responsibility.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing